Trade name
Rifadin
Presentation and preparation
|
Vial size
(powder volume) |
Fluid to add
|
Volume to add
|
Resulting concentration
|
|---|---|---|---|
| 600 mg (0.48 mL) |
Water for injections provided | 9.5 mL | 60 mg/mL |
Swirl gently to dissolve.
IV administration
Do not administer without further dilution.
Further dilute to 6 mg/mL or weaker and infuse over at least 30 minutes.
Other routes of administration
IM: Not recommended.
SC: Not recommended.
Compatible IV fluids
Glucose 5%
Sodium chloride 0.9%
Additional information
Extravasation risk.
Urine, saliva and other body fluids may become a red-orange colour during rifampicin treatment; soft contact lenses should not be worn as they may be permanently stained.
Reconstituted solution should be reddish brown.
Protect from light during storage.